Sign In
to Vote &
Create Storyboards.
 

Bristol-Myers' Pricey Pipeline

Wall Street Journal - 23 Jul 2015 19:48
Investors are excited about Bristol-Myers Squibb's pipeline, but high cancer-drug prices and insurance mergers are cause for concern.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard